Next Article in Journal
Prolonged Fasting Induces Histological and Ultrastructural Changes in the Intestinal Mucosa That May Reduce Absorption and Revert after Enteral Refeeding
Previous Article in Journal
Longitudinal Associations of Dietary Fructose, Sodium, and Potassium and Psychological Stress with Vascular Aging Index and Incident Cardiovascular Disease in the CARDIA Cohort
Previous Article in Special Issue
Effects of Lactobacillus plantarum and Weissella viridescens on the Gut Microbiota and Serum Metabolites of Mice with Antibiotic-Associated Diarrhea
 
 
Article
Peer-Review Record

Safety Assessment and Probiotic Potential Comparison of Bifidobacterium longum subsp. infantis BLI-02, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06, and Lactobacillus paracasei ET-66

Nutrients 2024, 16(1), 126; https://doi.org/10.3390/nu16010126
by Jui-Fen Chen 1, Ko-Chiang Hsia 1, Yi-Wei Kuo 2, Shu-Hui Chen 3, Yen-Yu Huang 1, Ching-Min Li 1, Yu-Chieh Hsu 1, Shin-Yu Tsai 1 and Hsieh-Hsun Ho 1,2,3,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Nutrients 2024, 16(1), 126; https://doi.org/10.3390/nu16010126
Submission received: 27 October 2023 / Revised: 25 December 2023 / Accepted: 28 December 2023 / Published: 29 December 2023
(This article belongs to the Special Issue The Probiotics and Prebiotics and Their Benefits for Health)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

Dear Authors,

I have some corrections:

Abstract must be shortened (up to a maximum of 200 words)

- the type of graph for figure 1 is not chosen appropriately because it is difficult to read, use another format if possible

 

Author Response

Dear reviewer:

We would like to express our sincere gratitude for providing valuable feedback on our manuscript titled "Safety Assessment and Probiotic Potential Comparison of Bifidobacterium longum subsp. infantis BLI-02, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06, and Lactobacillus paracasei ET-66."

We genuinely appreciate the time and attention you devoted to reviewing our manuscript. Your comments and suggestions have been thoroughly considered, and we are pleased to provide a detailed explanation of the modifications we have implemented based on your feedback. Followings are the point-to-point response to your comments.

 

Sincerely,

Hsieh-Hsun Ho

 

Comments 1: Abstract must be shortened (up to a maximum of 200 words)

Response 1: Thank you for reminding us about the length of the abstract. We have revised it to ensure conciseness and coherence.

 

Comments 2: The type of graph for figure 1 is not chosen appropriately because it is difficult to read, use another format if possible

Response 2: Thank you for pointing out the issues with the presentation of Figure 1. We have revised Figure 1 by incorporating color and adjusting the axis scales. We believe these adjustments will enhance readability.

Reviewer 2 Report

Comments and Suggestions for Authors

In this study, the authors assessed the safety and probiotic potential of four lactic acid bacteria strains via in vitro and in vivo experiments. While it is not clear whether the information reported here is new to the readership. Please revise the introduction to include more background on the four specific strains with a focus on the current understanding of their safety and probiotic potential. 

Besides, the claim that "the lyophilize powder of these fours strains is safe as probiotic supplement" is too strong. The in vitro and mice experiments in this study could not provide sufficient evidence to support this conclusion. 

Also, it is hard to identify specific groups in some of the figures due to the colors and patterns used, especially in Figure 4B. 

Comments on the Quality of English Language

The language is generally in good quality.

Author Response

Dear reviewer:

We would like to express our sincere gratitude for providing valuable feedback on our manuscript titled "Safety Assessment and Probiotic Potential Comparison of Bifidobacterium longum subsp. infantis BLI-02, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06, and Lactobacillus paracasei ET-66."

We genuinely appreciate the time and attention you devoted to reviewing our manuscript. Your comments and suggestions have been thoroughly considered, and we are pleased to provide a detailed explanation of the modifications we have implemented based on your feedback. Followings are the point-to-point response to your comments.

 

Sincerely,

Hsieh-Hsun Ho

 

Comments 1: In this study, the authors assessed the safety and probiotic potential of four lactic acid bacteria strains via in vitro and in vivo experiments. While it is not clear whether the information reported here is new to the readership. Please revise the introduction to include more background on the four specific strains with a focus on the current understanding of their safety and probiotic potential.

Response 1: Thank you for your valuable suggestions regarding the introduction. They have greatly contributed to improving the quality of our manuscript. We have provided additional information on the reasons for conducting safety studies on probiotics and enhanced the historical background of the four species of lactic acid bacteria, including the years of isolation for BLI-02, LPL28, TYCA06, and ET-66. Despite the classification of lactic acid bacteria as Generally Recognized as Safe (GRAS) for human consumption, the report published by the Food and Agriculture Organization (FAO)/World Health Organization (WHO) in 2002 emphasized the necessity of a systematic assessment of the safety of lactic acid bacteria. As BLI-02, LPL28, TYCA06, and ET-66 have demonstrated various functional properties, this study follows international guidelines for pharmaceutical and food safety assessments. High-dose toxicity experiments with these strains are conducted using animal models to investigate their safety. For details of the revised version, please see the attachment of the tracked revised manuscript.

 

Comments 2: Besides, the claim that "the lyophilize powder of these fours strains is safe as probiotic supplement" is too strong. The in vitro and mice experiments in this study could not provide sufficient evidence to support this conclusion.

Response 2: Thank you for your precious comments. The conclusion of the abstract has been revised to state, "the lyophilized powder of these four strains appears to be a safe probiotic supplement at tested dosages." The revised version could be found on line 28.

 

Comments 3: Also, it is hard to identify specific groups in some of the figures due to the colors and patterns used, especially in Figure 4B.

Response 3: Thank you for pointing out the issues with the presentation of Figure. We have revised Figure 1, Figure 3, and Figure 4 by incorporating color and adjusting the axis scales. We believe these adjustments will enhance readability.

 

Comments on the Quality of English Language: The language is generally in good quality.

Response: Thank you.

Round 2

Reviewer 2 Report

Comments and Suggestions for Authors

The comments and suggested changes have been properly addressed. Thank you for your efforts. 

Back to TopTop